Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEP-RB: Topotecan Episcleral Plaque for Retinoblastoma
NCT04428879Phase 1Completed
- Sponsor
- SickKids
- Start
- Jun 2020
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of topotecan in retinoblastoma (Rb), sponsored by SickKids. Primary endpoint: Maximum Tolerated Dose at 9 weeks. Started Jun 2020; status: completed.
02
Drugs
topotecan
03
Conditions
retinoblastoma (Rb)
Beyond the preview
Go deeper on NCT04428879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04428879.